Vishwa Kolla
Rashid Attar
Rashid Attar joined Qualcomm, San Deigo, CA, USA, and has involved in various aspects CDMA wireless data (EV-DO) and voice systems (IS-95, 1x-Advanced) in 1996, where he was the Project Engineer of CDMA2000-advanced from 2009 to 2013 and CDMA Modem Systems Lead at QCT from 20 through 2013. From 2014 to mid-2016, he led the ultra-low-power ASIC platform project. He is currently a Vice President Engineering with Corporate Research and Development, Qualcomm. He leads the ASIC and Hardware Department in Qualcomm Research. The Qualcomm Research portfolio consists of Communications (5G, Cellular V2X, Satellite Communications, Wi-Fi, and Industrial Internet of Things), ASIC and HW Research and Development, and Embedded IoE systems (Always on computer vision, Autonomous Driving, Robotics, and AR/VR). The ASIC and Hardware Group Research and Development portfolio consists of 5G (RFICs, PAs, Interfaces, Packaging), processors (CPUs, Programmable deep learning accelerators), ultra-low-power platform (processor, communications, memory, machine learning accelerators, power management, wireless charging), core CMOS Research and Development (3-DIC and Thermal-aware designs), and Antenna Design. He holds approximately 160 granted U.S. patents
Paul Inman
With a first degree in Molecular Biology and Biochemistry and more than 30 years' experience of litigating intellectual property disputes, Paul Inman draws on his deep sector insight to advise a wide variety of clients across many jurisdictions. While experienced across a range of industries, Paul specialises in the life sciences sector and has worked with clients ranging from multi-national businesses, pharma and medical device companies, to research bodies, chemical companies and small start-ups.
His work has included acting on high-profile pharmaceutical and biotech patent infringement and revocation actions in the UK Patents Court, and more recently on UPC actions. In addition, Paul's interest and expertise in the life sciences sector has seen him advise on regulatory work concerning European pharmaceutical bodies. He is also experienced in acting for a wide range of patent and design proprietors.
Whether "success" is measured by getting the right court order at the end of the dispute or evaluating and reaching the right commercial settlement between the parties beforehand, a thorough and balanced assessment on each case is critical. The ultimate aim for Paul is to provide his clients with well-rounded advice and guidance to ensure the best possible outcome.
Paul's background in molecular biology and biochemistry means he can take on highly complex pharmaceutical or biotechnological inventions, as easily as less technical (but equally important) mechanical patents and designs.
Successfully guiding clients through the maze of litigation is where Paul's strength lies, having now been involved over 30 years in the field of litigation with his cases leading to more than 60 reported judgments, ranging from the tribunals of the UK Patent Office (UKIPO) up to the UK Supreme Court (formerly the House of Lords), European Patent Office (EPO) and European Court of Justice (CJ EU).
As well as litigating in the English courts, Paul has co-ordinated and advised on IP and regulatory litigation matters across the globe, as far afield as the US, South Africa, Malaysia, the Philippines, Australia and New Zealand, and closer to home in the UPC, Scotland, Ireland, France, Germany, Holland, Denmark, Sweden. Norway, Belgium, Spain, Portugal, Italy and Greece.
Paul is ranked as a leading individual in Chambers UK for both Patent Litigation and Life Sciences. He is also recognised in the 'IAM Patent 1000' global rankings and in the 'Best Lawyers®' UK 2025 guide.
Valeria Sadovykh
